Addressing Antidepressant Controversies in Pregnancy – CAUSALab
CAUSALab shared a post on LinkedIn about a paper by Sonia Hernandez Diaz et al. published in NEJM:
“New publication in NEJM!
‘Untangling the Risks of Antidepressants in Pregnancy’
The letter (published November 22, 2025) addresses persistent controversy surrounding antidepressants during pregnancy, despite their status as one of the most commonly used and studied medications. The authors highlight confounding by maternal psychiatric as a key challenge confronted by observational studies.
‘[M]uch of what we know about risks posed by SSRIs during pregnancy necessarily comes from observational studies, which present substantial challenges in terms of both study design and interpretation of results.’
Authors: Sonia Hernandez Diaz (CAUSALab, Harvard Program on Perinatal and Pediatric Pharmacoepidemiology (H4P)), Krista Huybrechts (Harvard T.H. Chan School of Public Health, H4P), Brian Bateman (Stanford University School of Medicine)
Read the letter in NEJM Group Perspectives.”
Title: Untangling the Risks of Antidepressants in Pregnancy
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO